Correlation Between Pyridoxal 5’-Phospate Level And Valproic Acid In Epilepsy Children

I Gusti Ngurah Made Suwarba, Ni Putu Yunik Novayanti, I Gusti Lanang Sidiartha, Dewi Sutriani Mahalini

Abstract


Background: It is important to maintain the adequate level of vitamin B6 to ensure stable metabolism. Vitamin B6 serum level might decreased by absorption disturbance or increasing demand. Valproic acid increase the synthesis of serum GABAergic in the other hand vitamin B6 is required as cofactor for gamma-amino butyric acid (GABA) formation. The dosage and duration of valproic acid therapy might be correlated with vitamin B6 serum level. The aim of this study is to know the correlation between vitamin B6 serum level against dosage and duration of valproic acid therapy in children with epilepsy.

Materials and Methods: This is a cross sectional study to investigate the correlation between vitamin B6 serum level against dosage and duration of valproic acid therapy. The level of vitamin B6 serum was determined by checking vitamin B6 active form in serum, pyridoxal 5’-phospate (PLP).

Results: In this study, 37 epilepsy children with valproic acid duration therapy more than 3 months was enrolled. Fifty six percent epilepsy children were male, commonly on children age 1-5 years old. Spearman correlation coefficient test showed a significant weak negative correlation between vitamin B6 serum level and dosage of valproic acid (r=–0.35; p=0.03), and very weak negative correlation with valproic acid duration therapy (r=-0.08; p=0.59), however it was not significant.
Conclusion: There was a significant weak negative correlation between vitamin B6 serum level and very weak negative correlation with valproic acid duration therapy, but not significant in children with epilepsy.

Keywords: correlation, valproic acid, vitamin B6


Full Text:

PDF

References


Ueland PM, Ulvik A, Avila LR, Midttun Q, Gregory JF. Direct and functional biomarkers of vitamin B6 status. Annu Rev Nutr. 2015; 35: 33-70, CrossRef.

Tamura T, Aiso K, Johnston KE, Black L, Faught E. Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res. 2000; 40: 7-15, CrossRef.

Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, et al. Early effect of sodium valproat and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res. 2006; 71: 229-32, CrossRef.

Sener U, Zorlu Y, Karaguzel O, Ozdamar O, Coker I, Topbas M. Effect of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure. 2005; 15(2): 79-85, CrossRef.

Perucca E. Pharmalogical and therapeutic properties of valproat. A summary after 35 years of clinical experience. CNS Drugs. 2002; 16(10): 695-714, CrossRef.

Sweetman SC, editors. Martindale: The Complete Drug Reference. 35th ed. London: Pharmaceutical Press; 2007, Link.

Dave HN, Ramsay RE, Khan F, Sabharwal V, Irland M. Piridoxine deficiency in adult patients with status epilepticus. Epilepsy Behav. 2015; 52(Pt A): 154-8, CrossRef.

Merril AH, Henderson M. Disease associated with defects in vitamin B6 metabolite, or utilization. Ann Re Nutr. 1987; 7: 137-56, CrossRef.

Suwarba IGN. Insiden dan karakteristik klinis epilepsi pada anak. Sari Pediatri. 2011; 13(2): 123-8, Link.

Davis RE, Reed A, Smith BK. Serum pyridoxal, folate and vitamin B12 levels in institutionalized epileptics. Epilepsia. 1975; 16: 463-8, CrossRef.

Leklem J. Vitamin B6: a status report. J Nutr. 1990; 120 Suppl 11(4): 1503-7, CrossRef.

WHO and FAO. Vitamin B6. In: Vitamin and Mineral Requirements in Human Nutrition. 2nd edition. Bangkok: World Health Organization and Food and Agriculture Organization of the United Nations; 2004. p.175-9, Link.

Institute of Medicine. Vitamin B6. In: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington DC: National Academy Press; 1998. p.150-95, Link.

Vilaseca MA, Monrós E, Artuch R, Colomé C, Farré C, Valls C, et al. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C,T mutation of methylenetetrahydrofolate reductase gene. Eur J Paediatr Neurol. 2000; 4(6): 269-77, CrossRef.

Ahmad I, Mirza T, Qadeer K, Nazim U, Vaid FHM. Vitamin B6: Deficiency diseases and methods of analysis. Pak J Pharm Sci. 2013; 26(5): 1057-69, Link.

Greenfield LJ. Molecular mechanisms of antiseizure drug activity at GABAA reseptors. Seizure. 2013; 22(8): 589-600, CrossRef.




DOI: https://doi.org/10.21705/mcbs.v3i1.38

Copyright (c) 2019 I Gusti Ngurah Made Suwarba

Indexed by:

                     

                    

                    


Cell and BioPharmaceutical Institute